Teaching Team – Hands-on training in clinical medicine and emergencies Summer School

Dr Lara NOKOVITCH is a maxillo-facial surgeon specialized in head and neck oncology and facial reconstructive surgery at Beaujon University Hospital (AP-HP). She holds two MSc, one in Human Physiopathology and one in Healthcare Training Engineering. She authored numerous publications in international journals, and has been involved in national and international conferences. She is an active member of several professional societies, including the French Society of Head and Neck Oncology (SFCCF), and the French Group for Head and Neck Cancer Study (GETTEC). She is currently pursuing a PhD in educational sciences at the Laboratory of Education and Health Practices (LEPS – UR 3412) at Sorbonne Paris Nord University. Her research aims to improve surgical trainees’ knowledge in anatomy. She also teaches anatomy to medical students at UPCité Medical School.

Dr Michael THY is a University Hospital Practitioner in Intensive Care and Infectious Diseases at Bichat Hospital (AP-HP, Paris), with a PhD in Pharmacology and a Master’s in Biostatistics. His expertise spans severe infections, sepsis, antimicrobial stewardship and pharmacokinetics in critically ill patients. He is also a certified simulation instructor, trained at iLumens, where he leads both low- and high-fidelity interprofessional simulation workshops, with a special focus on infectious diseases in intensive care as part of the DURPI (Diplôme Universitaire de Réanimation en Pathologie Infectieuse). Throughout his career, Dr. Thy has been affiliated with leading research laboratories, first as a PhD student at EA 7323 – Pharmacology and Therapeutic Evaluation in Children and Pregnant Women (Université Paris Cité), and later as a researcher at INSERM UMR1137, IAME (Université Paris Cité, Paris, France). A prolific researcher, he has authored numerous publications in high-impact journals and regularly presents his work at national and international conferences.

Dr Lina KHIDER is a vascular medicine physician at the European Georges Pompidou Hospital (AP-HP) and an academic faculty member at Université Paris Cité. She is involved in both clinical and translational research on venous thromboembolism, with a particular focus on post-thrombotic syndrome and endothelial dysfunction. She contributes to several national and collaborative projects within the INSERM U970 laboratory and the Physics for Medicine team (U1273), exploring ultrasound-based venous recanalization approaches and genetic determinants of venous thromboembolism sequelae. Committed to medical education, she coordinates the training of standardized patients for OSCEs and is involved in the development of AI-based simulation tools to enhance the authenticity of learning experiences.

Dr Benedicte OULES is a dermatologist at Cochin University Hospital (AP-HP) and a researcher at Institut Cochin (Inserm U1016, CNRS UMR 8104). She specializes in onco-dermatology and inflammatory dermatoses, particularly hidradenitis suppurativa and acne. She is an active member of the French Society of Dermatology (SFD), and serves as the secretary of the hidradenitis suppurativa taskforce of the SFD (HS-France). In addition, she received a PhD in Cell and Molecular Biology in 2009, and completed a post-doctoral fellowship at King’s College London (UK) from 2015 to 2018. Her current research areas include inflammatory dermatoses, wound healing, and translational dermatology. She currently leads a group in the Cutaneous Biology Lab at Institut Cochin aimed at improving our understanding of the pathogenesis of hidradenitis suppurativa.

Dr Jules MESNIER is an interventional cardiologist at Bichat University Hospital (AP-HP), specialized in complex coronary interventions and percutaneous structural heart procedures. He holds a master’s degree in fundamental science, having worked on the biocompatibility of coronary stents. He spent two years as a research and clinical fellow at the Institut Universitaire de Pneumologie et de Cardiologie de Québec (IUCPQ), Québec, Canada, where he completed a PhD in clinical science. He is a member of the INSERM Unit U1148, with which he conducts clinical research using large national and international databases on patients with coronary artery disease, focusing on precision medicine and the use of AI models to improve the efficacy and safety of therapeutic management. He also studies percutaneous structural heart interventions through local and international collaborative databases.

Dr Alexis TALBOT is an Associate Professor in Immuno-Hematology at Saint-Louis Hospital (AP-HP, Paris) and a physician-scientist (MD, PhD) specializing in hematological and plasma cell disorders. He provides clinical care for patients with multiple myeloma and monoclonal gammopathies of clinical significance (MGCS), as his center is a national reference site for these rare diseases. He is a member of the French Society of Hematology, the European Hematology Association, and the French Society for Immunology and of the International Myeloma Society. He also serves as a board member of the French Myeloma Group (IFM). Dr. Talbot completed his postdoctoral fellowship at the Gladstone Institutes, University of California San Francisco (UCSF), in the laboratory of Dr. Justin Eyquem, where he investigated synthetic immunology approaches and CAR T-cell engineering strategies. He conducts his research within the UMR 1342 Immunopathology and Innovative Therapies Laboratory (Université Paris Cité / INSERM), where his team focuses on next-generation CAR T-cell therapies for multiple myeloma. His work aims to engineer novel T-cell platforms and elucidate mechanisms of resistance to cellular immunotherapies.